The Pain Point: Hemorrhage Is Predictable, Not Random

Abdominal haemorrhage during PTCD has three recognised causes: rupture of the liver capsule, injury to a vessel of significant calibre along the puncture track, and impaired coagulation. All three are addressable before and during the procedure. Yet haemorrhage continues to be reported as an unpredictable complication, largely because the contributing factors are treated as background conditions rather than as design parameters.

The clinical consequences are disproportionate. A patient with malignant biliary obstruction is often anaemic, hypoalbuminaemic, and coagulopathic; a bleed that would be tolerated by a healthy patient can precipitate decompensation, transfusion, and a prolonged admission. It can also obscure the access that took five passes to achieve. The cost of prevention is a preoperative injection, a different needle gauge, and a few extra minutes of planning. The cost of a bleed is measured in days.

How the Puncture Track Behaves Under Pressure

A needle track through liver parenchyma is not an open channel. The liver is a vascular, elastic organ, and a narrow track through it is compressed by surrounding tissue - the parenchymal tamponade effect. The magnitude of that effect depends on the length of the track through parenchyma, the diameter of the instrument, and the elasticity of the tissue. A long track through normal parenchyma seals quickly. A short, large-bore, transcapsular track seals poorly.

Arterial injury is the most consequential. Hepatic arterial branches run with the portal triads, and a needle that crosses a triad at any point in its course may injure an arterial branch. The risk rises with the number of passes and with the diameter of the instrument. Venous injury - portal or hepatic vein - is more common and usually self-limiting, because pressures are lower and tamponade is effective.

Capsular rupture is a distinct mechanism. It occurs when the needle or catheter is manipulated laterally at the capsule, or when a stiff instrument is advanced through a tough capsule under force, tearing rather than puncturing. The resulting subcapsular haematoma can be substantial and can progress after the procedure appears complete.

Coagulation interacts with all of these. Abnormal clotting does not create a bleeding vessel, but it prevents the track from sealing once one is created. That is why the combination of multiple passes and abnormal coagulation is the highest-risk pattern in reported series.

Needle and System Factors That Reduce Bleeding

Gauge is the most direct lever. Fine needles in the 21G–22G range create smaller tracks with less vascular disruption and are the appropriate default in coagulopathic patients where the anatomy permits. Standard 18G–19G needles remain acceptable where wire support is needed; their risk is manageable if the number of passes is controlled. Large-bore introducer systems should be reserved for specific drainage requirements and used with a planned single pass.

Tip geometry influences the character of the injury. Cutting bevels produce clean linear tracks that seal more reliably than torn or dilated tracks. Diamond and conical tips dilate, which can be advantageous for duct entry but produces more tissue disruption along the track and should be weighed against bleeding risk in a coagulopathic patient.

Surface finish and shaft stiffness affect the force required to advance. A rough or poorly finished cannula requires more force, and more force means less control and more lateral trauma at the capsule. A polished, plated, or ultrasonically cleaned surface reduces friction and insertion force - a small engineering detail with direct clinical consequence.

Track length is a design decision the operator controls through approach selection. A lateral intercostal approach through the right lobe provides a long parenchymal track that tamponades effectively. An anterior approach to the left system provides a shorter track and requires more attention to catheter fixation and to post-procedural observation.

Catheter-to-needle sizing matters at the transition. Dilating a fine needle track to accept a larger catheter creates a track that is temporarily larger than the catheter, which is the interval during which leakage and bleeding occur. Stepwise dilation over a wire, with the catheter advanced immediately behind the dilator, minimises that interval.

A Practical Guide to Bleeding Prevention

Screen before you puncture. Check platelet count, prothrombin time, and international normalised ratio, and correct what can be corrected. Where coagulation is impaired, intramuscular vitamin K1 preoperatively is a reasonable step, and hemostatic support continued for approximately three days post-procedure is a commonly used protocol.

Plan for a single pass in the high-risk patient. Fine-needle technique should be used as far as possible during puncture. If imaging shows that a fine needle cannot reach the target safely, reconsider the approach rather than escalating gauge in the same trajectory.

Choose the long track when both are available. The tamponade effect is the body's own hemostatic mechanism; use it deliberately.

Avoid lateral force at the capsule. Advance straight, and if redirection is needed, withdraw to the capsule and re-angle rather than sweeping the tip inside the liver.

Observe for the signs that precede a crisis. Post-procedural tachycardia, falling haemoglobin, and right upper quadrant pain within the first hours are more informative than the appearance of the drainage bag. Do not allow a period of fasting for two hours after the procedure to delay recognition; fasting protects against aspiration, it does not substitute for monitoring.

Keep angiography and embolisation available. Most track bleeding responds to general hemostatic measures, but arterial injury may require angiography and embolisation. The decision to escalate should be made early, not after repeated transfusions.

Watch the first six hours more closely than the first six days. Track bleeding in a coagulopathic or multi-pass patient declares itself early: tachycardia that does not match the patient's temperature, a falling haemoglobin on the first post-procedural sample, right upper quadrant pain that is disproportionate to the size of the catheter, and a drainage bag that contains blood rather than bile. None of these findings is specific on its own, which is precisely why they should be recorded as a set. A stable patient at four hours with a normal pulse and unchanged haemoglobin is reassuring; a patient whose pulse has drifted upward by twenty beats per minute is not, regardless of how the puncture site looks.

Field Experience: The Patterns That Repeat

Reported series converge on a consistent finding: the dominant risk factor for haemorrhage after PTCD is the number of needle passes, followed by coagulation status at the time of the procedure. Technical refinements that reduce passes - pre-procedure trajectory planning, appropriate gauge for duct calibre, correct tip geometry for wall character - reduce bleeding more reliably than any post-hoc hemostatic measure.

A frequently observed failure mode is the "rescue dilation." Access has been achieved after several passes; the operator dilates quickly to secure the drainage catheter, and the track, already traumatised, bleeds. The corrective habit is to confirm wire position, dilate in controlled steps, and advance the catheter promptly behind the dilator.

Another pattern concerns patients whose coagulation was borderline and was not corrected because the procedure was considered urgent. In obstructed, infected systems, urgency is real. The practical resolution is not to delay the procedure but to change the instrument: fine needle, single planned pass, long track, and hemostatic support continued afterwards.

Summary: Bleeding Is a Design Problem

Haemorrhage after PTCD is not an accident that happens to unlucky operators. It is the predictable result of track diameter, track length, pass count, and coagulation status interacting. Each of these can be addressed: gauge selected by duct calibre and coagulation, tip geometry selected for clean track formation, surface finish selected for low insertion force, approach selected for long parenchymal track, dilation performed in controlled steps, and coagulation corrected preoperatively. The instrument and the technique are the same decision made twice.

Outlook: Turning Prevention into Protocol

The realistic improvement in the coming years is procedural rather than technological: standardising a preoperative coagulation checklist, recording pass count and track length in the procedure note, and defining an escalation threshold for angiography that does not depend on the operator's tolerance for uncertainty. On the supply side, the useful contribution is consistency - documented surface finish, verified tip geometry, and gauge availability across the full clinical range so that the fine-needle option always exists when the patient needs it. When prevention is written into the protocol, bleeding after PTCD becomes a rare event rather than a known hazard.

< img alt="news-1-1" src="/uploads/24240/news/202604241539186d0ff.png " />